Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism

British Journal of Dermatology

Volumn 156, Issue 2, 2007, Pages 277-282

  Santonocito, C ^a   Capizzi, R ^a   Concolino, P ^a   Lavieri, M M ^a   Paradisi, A ^a   Gentileschi, S ^b   Torti, E ^a   Rutella, S ^a   Rocchetti, S ^a   Di Carlo, A ^c   Di Stasio, E ^a   Ameglio, F ^a   Zuppi, C ^a   Capoluongo, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

BsmI; Melanoma; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOLECULAR TYPING; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN; STATISTICAL SIGNIFICANCE; THICKNESS;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; REGRESSION ANALYSIS; SKIN NEOPLASMS;

EID: 33846245970     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07620.x     Document Type: Article

References (38)

1. Schaffer JV, Rigel DS, Kopf AW et al. Cutaneous melanoma: past, present and future. J Am Acad Dermatol 2004; 51 (Suppl. 1):S65-9.
2. Ferlay J, Bray S, Pisani P et al. GLOOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0, Cancer Base No. 5. Lyon: IARC Press, 2000.
3. De Carli A, La Vecchia C. Environmental factors and cancer mortality in Italy: correlational exercise. Oncology 1986; 43:116-26.
4. Nagpal S, Na S, Rathnachalam R. Non-calcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26:662-87.
5. Uitterlinden AG, Fang Y, van Meurs JB et al. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol 2004; 89-90:187-93.
6. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays 2004; 26:21-8.
7. Gregori S, Giarratana N, Smiroldo S et al. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003; 171:4040-7.
8. Hayes CE, Nashold FE, Spach KM et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-Grand) 2003; 49:277-300.
9. 3, and the immune system. Am J Clin Nutr 2004; 80:S1717-20.
10. Cantorna MT, Munsick C, Bemiss C et al. 1, 25dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 11:2648-52.
11. 3 - a hormone with immunomodulatory properties. Z Rheumatol 2000; 59 (Suppl. 1):24-7.
12. 3 on melanoma cell lines in vitro. J Steroid Biochem Mol Biol 2004; 89-90:375-9.
13. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr 2005; 135:310-16.
14. Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 2002; 147:197-213.
15. Uitterlinden AG, Fang Y, van Meurs JB et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338:143-56.
16. Long JR, Zhao LJ, Liu PY et al. Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. BMC Genet 2004; 24:5-11.
17. Sillanpaa P, Hirvonen A, Kataja V et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 2004; 14:239-45.
18. Peters U, Hayes RB, Chatterjee N et al. Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004; 13:546-52.
19. Hutchinson PE, Osborne JE, Lear JT et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 6:498-504.
20. Halsall JA, Osborne JE, Potter L et al. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Br J Cancer 2004; 91:765-70.
21. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-48.
22. Fitzpatrick TB. The validity and practicability of sun reaction skin types I through VI. Arch Dermatol 1988; 124:869-71.
23. Gross C, Krishnan AV, Malloy PJ et al. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998; 13:1691-9.
24. Fargnoli MC, Piccolo D, Altobelli E et al. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res 2004; 14:151-7.
25. Ford D, Bliss JM, Swerdlow AJ et al. Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 1995; 62:377-81.
26. Millen AE, Tucker MA, Hartge P et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13:1042-52.
27. Nichaman MZ, Olson RE, Weeley CC. Metabolism of linoleic acid-1-14-C in normolipemic and hyperlipemic humans fed linoleate diets. Am J Clin Nutr 1967; 20:1070-83.
28. Adam O, Wolfram G. Effect of different linoleic acid intakes on prostaglandin biosynthesis and kidney function in man. Am J Clin Nutr 1984; 40:763-70.
29. Black AK, Fincham N, Greaves MW et al. Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2α in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 1980; 10:453-7.
30. Williams RR. Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, TSH and MSH. Lancet 1976; i:996-9.
31. Anstey AV. Systemic photo protection with α-tocopherol (vitamin E) and β-carotene. Clin Exp Dermatol 2002; 27:170-6.
32. Stahl W, Sies H. Carotenoids and protection against solar UV radiation. Skin Pharmacol Appl Skin Physiol 2002; 15:291-6.
33. Rosdahl I, Andersson E, Kagedal B et al. Vitamin A metabolism and mRNA expression of retinoid-binding protein and receptor genes in human epidermal melanocytes and melanoma cells. Melanoma Res 1997; 7:267-74.
34. 3 in human malignant melanoma cell lines. J Surg Res 1996; 61:127-33.
35. 3 and its analogues. Cell Death Differ 1998; 5:946-52.
36. Riggs BL, Nguyen TV, Melton LJ III et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995; 10:991-6.
37. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22:203-17.
38. Capoluongo E, Pitocco D, Concolino P et al. Slight association between type 1 diabetes and 'ff ' VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 2006; 39:888-92.